Coca-Cola Consolidated, Inc.
COKE
$175.00
+1.67%
Coca-Cola Consolidated, Inc. is the largest independent Coca-Cola bottler in the United States, operating in the non-alcoholic beverage industry with a core business of manufacturing, marketing, and distributing a wide portfolio of sparkling and still beverages, including the flagship Coca-Cola brand. The company is a key strategic partner within The Coca-Cola system, serving a significant portion of the U.S. Southeast and Mid-Atlantic, which provides it with a stable, franchise-based business model. The current investor narrative revolves around its demonstrated pricing power and resilient volume performance in a defensive sector, though recent financial results show a mix of revenue growth and margin pressures, with the stock experiencing significant volatility following its latest earnings release.…
COKE
Coca-Cola Consolidated, Inc.
$175.00
Investment Opinion: Should I buy COKE Today?
Rating & Thesis: Hold. COKE presents a complex, high-risk/high-potential-reward profile where severe margin pressures and catastrophic volatility offset compelling cash generation and a deep-value forward valuation. The lack of a clear analyst consensus or price target underscores the uncertainty, making a definitive Buy or Sell call premature without clarity on the margin trajectory.
Supporting Evidence: The primary valuation metric, the forward P/E of 4.51x, is exceptionally low and suggests the market is pricing in significant earnings deterioration. Revenue growth remains positive at 9.03% YoY, but is decelerating. Profitability is the critical concern, with gross margin contracting 145 bps YoY. The company's strength is its substantial TTM free cash flow of $620.25 million, which provides a margin of safety. The stock's 0.60 beta indicates a defensive profile, but this is contradicted by its recent extreme volatility.
Risks & Conditions: The two biggest risks are persistent gross margin compression and the stock's high volatility driven by low liquidity and sparse coverage. This Hold rating would upgrade to a Buy if the company demonstrates gross margin stabilization above 39% in the next quarter, or if the stock approaches its 52-week low near $105, offering a greater margin of safety. It would downgrade to a Sell if QoQ revenue growth turns negative or if free cash flow generation meaningfully deteriorates. Based on the conflicting signals, the stock is currently fairly valued for its elevated risk profile, but deeply undervalued if margins can recover.
Sign up to view all
COKE 12-Month Price Forecast
The outlook for COKE is bifurcated, hinging almost entirely on operational execution to halt margin erosion. The base case of range-bound volatility is most probable, given the conflicting signals of strong cash flow versus profit pressure. The forward P/E of 4.51x is too low to ignore but reflects legitimate fears about earnings sustainability. The stance would upgrade to bullish on concrete evidence of margin recovery in the next 1-2 quarters, supported by the stock's defensive beta and cash generation. It would turn bearish if the next earnings report shows accelerated margin decline or volume weakness, validating the recent crash and opening a path to the 52-week low.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Coca-Cola Consolidated, Inc.'s 12-month outlook, with a consensus price target around $227.50 and implied upside of +30.0% versus the current price.
Average Target
$227.50
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$140 - $228
Analyst target range
Analyst coverage for COKE is extremely limited, with only one analyst providing estimates, indicating insufficient coverage for a reliable consensus. The single analyst provides a revenue estimate of $7.228 billion but no EPS or price target data, which precludes calculation of a consensus target or implied upside/downside. This lack of coverage typically characterizes smaller or less-followed companies and can lead to higher volatility and less efficient price discovery, as the stock price is driven more by direct investor sentiment and company-specific news rather than institutional research; the absence of recent rating actions (the latest available is from 2016) further underscores the stock's niche status within the investment community.
Bulls vs Bears: COKE Investment Factors
The investment debate for COKE centers on a clash between its strong underlying cash generation and defensive business model against severe profitability pressures and recent catastrophic price action. The bear case currently holds stronger short-term evidence, given the dramatic technical breakdown and clear margin compression that directly threatens earnings. However, the bull case is supported by deep-value signals from the extraordinarily low forward P/E and the stock's significant retreat from highs. The single most important tension is whether the gross margin contraction (38.21% in Q4) is a temporary headwind or a structural shift that will prevent the company from realizing the earnings implied by its forward P/E of 4.51x. The resolution of this margin pressure will determine if the stock is a value trap or a compelling turnaround opportunity.
Bullish
- Strong Free Cash Flow Generation: The company generated $620.25 million in TTM free cash flow, providing significant financial flexibility for shareholder returns or strategic investments. This robust cash generation underpins the business model's resilience and supports the stock's defensive characteristics.
- Resilient Revenue Growth: Q4 2025 revenue grew 9.03% year-over-year to $1.904 billion, demonstrating the company's ability to grow its top line in a mature industry. This growth, while decelerating, shows continued pricing power and volume stability within its franchise territories.
- Attractive Forward P/E Valuation: The stock trades at a forward P/E of 4.51x, which is exceptionally low and suggests the market is pricing in minimal growth or potential earnings volatility. This creates a significant valuation gap versus its trailing P/E of 19.79x, offering potential upside if earnings stabilize.
- Defensive Profile with Low Beta: A beta of 0.60 indicates the stock is historically 40% less volatile than the broader market, a trait attractive during economic uncertainty. This low correlation to the S&P 500, combined with its consumer defensive sector, provides portfolio diversification benefits.
Bearish
- Severe Gross Margin Contraction: Q4 2025 gross margin contracted to 38.21% from 39.66% in Q4 2024, a 145 basis point decline indicating pressure from input cost inflation or unfavorable product mix. This erosion directly impacts profitability, as net income for the quarter was $137.25 million, down from $178.95 million in the year-ago period.
- Extreme Volatility & Technical Breakdown: The stock suffered an 18% single-day collapse from $210.52 to $177.61 on May 7, 2026, breaking key technical support and signaling a major shift in sentiment. This high volatility contradicts its low beta and suggests company-specific issues are driving price action, with the stock now down 3.67% over three months while the S&P 500 gained 8.15%.
- Anomalous & Distorted Balance Sheet Metrics: A debt-to-equity ratio of -4.06 and a negative ROE of -77.13% are caused by negative shareholder equity, likely due to aggressive share buybacks. These distorted metrics make traditional financial health assessments difficult and mask the company's true leverage and capital structure risks.
- Minimal Analyst Coverage & Visibility: Only one analyst covers the stock, providing a revenue estimate but no EPS or price target, leading to poor price discovery and higher volatility. The lack of a consensus target or recent rating actions (latest from 2016) increases investment uncertainty and reflects its niche status.
COKE Technical Analysis
The stock is in a volatile, corrective phase following a failed breakout attempt, currently trading at approximately 79.9% of its 52-week range (from a low of $105.21 to a high of $219.65), indicating it has retreated meaningfully from recent highs. Despite a strong 1-year gain of 55.3%, the recent price action has been negative, with the stock down 6.28% over the past month and 3.67% over the past three months, signaling a sharp reversal of its previous uptrend and a breakdown from the $200+ level. The stock's beta of 0.60 suggests it is historically 40% less volatile than the broader market (SPY), which is notable given its recent price swings and indicates company-specific catalysts are likely driving the current turbulence. Key technical support resides near the 52-week low of $105.21, while immediate resistance is at the recent highs around $219.65; the dramatic 18% single-day drop on May 7th, 2026, from $210.52 to $177.61, represents a critical breakdown level that now serves as formidable overhead resistance, suggesting the path of least resistance may be lower unless this zone is reclaimed.
Beta
0.60
0.60x market volatility
Max Drawdown
-24.7%
Largest decline past year
52-Week Range
$105-$220
Price range past year
Annual Return
+55.1%
Cumulative gain past year
| Period | COKE Return | S&P 500 |
|---|---|---|
| 1m | -14.2% | +5.4% |
| 3m | -15.6% | +10.9% |
| 6m | +5.6% | +11.0% |
| 1y | +55.1% | +28.1% |
| ytd | +16.8% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COKE Fundamental Analysis
Revenue growth remains positive but has decelerated, with Q4 2025 revenue of $1.904 billion representing a 9.03% year-over-year increase; however, this marks a sequential slowdown from the double-digit growth seen in prior quarters of 2025, indicating potential normalization post-pandemic or increased competitive pressures. Profitability is robust but under pressure, as evidenced by Q4 net income of $137.25 million and a gross margin of 38.21%, which has contracted from the 39.66% reported in Q4 2024, suggesting input cost inflation or mix shifts are compressing profitability despite top-line growth. The balance sheet shows significant financial strength with substantial free cash flow generation of $620.25 million (TTM) and a healthy current ratio of 1.26, but the reported debt-to-equity ratio of -4.06 is anomalous and likely driven by negative shareholder equity due to accounting for share repurchases, a factor that inflates Return on Equity (ROE) to an unrealistic -77.13% and requires careful interpretation of the company's true leverage.
Quarterly Revenue
$1.9B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$620252000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COKE Overvalued?
Given a positive net income of $137.25 million in the latest quarter, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The stock trades at a trailing P/E of 19.79x and a significantly lower forward P/E of 4.51x, with the wide gap suggesting analysts expect a substantial rebound in earnings, though the forward estimate appears unusually low and may warrant scrutiny. Compared to sector averages, COKE's trailing P/E of 19.79x and Price-to-Sales (P/S) of 1.56x are not directly comparable without industry benchmark data provided; however, the P/S ratio of 1.56x suggests a moderate sales multiple for a capital-intensive bottler. Historically, the stock's own trailing P/E has fluctuated significantly, ranging from approximately 10.6x to over 75x in recent years; the current 19.79x sits below the peak but above the lower end of this range, suggesting a valuation that is not stretched but also not deeply discounted relative to its own history, especially considering the recent price correction.
PE
19.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 8x~76x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is profitability erosion, as evidenced by the 145 basis point year-over-year contraction in Q4 gross margin to 38.21%. This directly pressured net income, which fell 23% from the prior year's Q4. The balance sheet presents interpretative challenges with a debt-to-equity ratio of -4.06 and negative ROE, distortions stemming from negative equity due to share repurchases, which complicates leverage assessment. While free cash flow of $620 million (TTM) is strong, dependence on continued pricing power to offset input cost inflation is a key operational risk, especially if volume growth stalls from its current 9% rate.
Market & Competitive Risks: The stock faces significant valuation compression risk, trading at a trailing P/E of 19.79x but a forward P/E of 4.51x—a gap that implies extreme earnings growth expectations which may not materialize if margins keep falling. Its low beta of 0.60 suggests it should be less volatile, yet the 18% single-day drop demonstrates company-specific risk dominates, potentially linked to earnings disappointments or guidance cuts. As a capital-intensive bottler with a P/S of 1.56x, it is also exposed to sector rotation away from consumer staples if investors seek higher growth, and competitive pressures from private label and other beverage categories could further squeeze its franchise model.
Worst-Case Scenario: The worst-case scenario involves a continuation of the Q4 margin decline coupled with a volume slowdown, leading to a double-digit percentage drop in earnings. This could trigger a re-rating to a P/E multiple in line with its historical low near 10.6x, compounded by the stock's illiquidity and lack of analyst support. A realistic downside target aligns with the 52-week low of $105.21, which would represent a loss of approximately -40% from the current price of ~$175. This scenario could be catalyzed by another earnings miss, a guidance withdrawal, or a broader recession impacting consumer spending in its regional markets.
FAQ
The key risks are, in order of severity: 1) Profitability Risk: Continued gross margin compression, as evidenced by the drop from 39.66% to 38.21% YoY in Q4, which directly threatens earnings. 2) Liquidity & Sentiment Risk: Extremely low analyst coverage and the recent 18% single-day crash indicate poor price discovery and potential for sharp, sentiment-driven declines. 3) Financial Statement Distortion Risk: Anomalies like a negative debt-to-equity (-4.06) and ROE (-77.13%) due to negative equity make traditional analysis difficult and could mask underlying leverage. 4) Growth Deceleration Risk: Revenue growth slowed to 9.03% in Q4 from higher rates, raising sustainability concerns.
The 12-month forecast is highly uncertain due to sparse analyst coverage, but three scenarios are plausible. The base case (55% probability) sees the stock trading between $150 and $180 as margin pressures moderate but persist. The bull case (25% probability), fueled by margin recovery, targets a return to the $200-$219 range. The bear case (20% probability), involving further earnings deterioration, could drive the stock toward its 52-week low of $105. The base case is most likely, assuming the company's strong free cash flow provides a floor but margin issues limit upside. The key assumption is the trajectory of the Q4 gross margin of 38.21%.
COKE sends conflicting valuation signals. Based on trailing earnings (P/E of 19.79x), it appears fairly valued for a stable bottler. However, the forward P/E of 4.51x is extraordinarily low and suggests the stock is deeply undervalued if forward earnings estimates are accurate. This massive gap implies the market expects a severe earnings decline. Compared to its own history, with a P/E range from 10.6x to 75x, the current trailing multiple is in the lower-middle range. The valuation is therefore bifurcated: it is undervalued on a forward basis but this discounts significant operational risk, making it fairly valued on a risk-adjusted basis today.
COKE is a high-risk, potentially high-reward stock that is not a straightforward 'good buy' for most investors. The forward P/E of 4.51x suggests deep value, but this is counterbalanced by clear margin pressures, as seen in the 145 bps gross margin contraction in Q4. The 18% single-day crash in May 2026 highlights extreme volatility and sentiment risk. It could be a good buy for deep-value, contrarian investors with a high risk tolerance and a long time horizon who believe the margin issue is temporary. For the average investor seeking stability, it is a Hold at best, given the significant uncertainty.
COKE is unsuitable for short-term trading due to its low beta (0.60) being contradicted by recent extreme volatility and low liquidity, which can lead to unpredictable price gaps. Its investment thesis revolves around a fundamental operational turnaround (margin recovery), which typically requires multiple quarters to materialize and confirm. Therefore, it is only suitable for a long-term investment horizon of a minimum of 2-3 years, allowing time for the company to demonstrate whether it can stabilize profitability and for the valuation gap (4.51x forward P/E) to potentially close. The lack of a meaningful dividend (yield 0.77%) further supports a growth/turnaround, long-term holding period.
